published meta-analysis   sensitivity analysis   studies

dexamethasone in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsRanjbar, 2021 (REV) 2.50 [0.93; 6.75] 2.50[0.93; 6.75]Ranjbar, 2021 (REV)10%86NAnot evaluable mechanical ventilationdetailed resultsRanjbar, 2021 (REV) 2.77 [1.03; 7.43] 2.77[1.03; 7.43]Ranjbar, 2021 (REV)10%86NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-11-01 00:41 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 666,1149,1150 - roots T: 290